PROVID-CAPSyS - Systems Medicine of COVID-19, extension Study on PROVID-PROGRESS

• Conditions: U07.1; J13; COVID-19, virus identified; Pneumonia due to Streptococcus pneumoniae; J14; J15; J17; J18; Pneumonia due to Haemophilus influenzae; Bacterial pneumonia, not elsewhere classified

• Registration Number: DRKS00023389
• Lead Sponsor: Charité – Universitätsmedizin Berlin, Med. Klinik m. S. Infektiologie und Pneumologie und Arbeitsbereich pulmonale Inflammation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

Positive detection of SARS-CoV-2-virus, ventilation (invasive, non-invasive, high-flow, ECMO), informed consent

Exclusion Criteria

Patient participation in PROVID-CAPNETZ, PROVID-PROGRESS or PROVID-CAPSyS at an earlier time, simultaneous participation in PROVID-CAPNETZ, pregnancy, breast feeding, active tuberculosis

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
death

Secondary Outcome Measures

Name	Time	Method
ength of hospitalization<br>length of ICU treatment<br>length of mechanical ventilation<br>organ involvement (complications)<br>long-term effects<br>changes in quality of life<br>